Plus: Is glucose monitoring really useful for people without diabetes?
New Scientist's Health Check Newsletter

Received this from a friend?
Sign up now to get every issue direct to your inbox each week

 

Top health stories this week

An older lady places her feet onto arrows on a mat

Dancing practice improves balance

NeuRA

Dance mat-style game helps stop older people falling

 

Why does the UK want to ban disposable vapes and when will it happen?

 

CRISPR gene therapy seems to cure dangerous inflammatory condition

 

 

Like what you see? Subscribe today to gain unlimited access to all our subscriber only content.

Subscribe now

 

Hi readers,

 

If you are of a certain age (as I am) you may remember the worst health scare of the 1990s – the discovery that changes in cattle farming practices were behind an explosion of “mad cow disease” cases in the UK. Worse, it was also possible for people who ate contaminated beef to catch a newly discovered human version of this condition, called variant Creutzfeldt-Jakob disease (vCJD).

 

While horrifying, it was also a fascinating time for medicine, as we learned about an entirely new kind of infection process. vCJD turned out to be rare, thankfully, but in the past few years it has emerged that the same process may be at work in some cases of Alzheimer’s disease and strokes.

 

Now, a study out this week has strengthened that idea, which has implications for our understanding of Alzheimer’s mechanisms more generally.

 

I’ll get to that study shortly, but first, some background. Previously, we thought that all infectious conditions were caused by either bacteria, viruses, fungi or parasites, such as the one that causes amoebic dysentery. 

 

But mad cow disease is caused by something different: a certain protein molecule that can exist in two different three-dimensional shapes. One is the normal version and one is the harmful or “misfolded” form.

 

Misfolded proteins can spread their shape to normal ones in a slow-motion cascade, like a line of dominos knocking each other down. And if a misfolded protein somehow gets into another animal or person’s body, the chain reaction can jump between individuals like an infection.

 

A gloved hand holds a laboratory vial in front of a background of brain scans

The exact causes of Alzheimer's are unclear

Teek Image/SPL/Alamy

The idea was initially seen as medical heresy, but, eventually, it was shown to be completely correct. Mad cow disease arose because, in the UK, cattle feed had started being made with the remains of other animals. When a misfolded version of a molecule called prion protein present in some feed spread through the recipient animals’ brains, it caused progressive neurodegeneration that was inevitably fatal.

 

Once this was understood, millions of British cattle had to be destroyed, there was a global export ban on British beef for several years and the rules on animal feed were changed around the world.

 

It also sparked panic over the potential number of human cases. Fortunately, it is now thought that only people with certain variants of the prion gene are susceptible to catching vCJD in this way. Less than 200 people are thought to have been affected, all of whom have sadly died.

 

But eating contaminated beef turned out not to be the only way vCJD can spread. Until the 1980s, children of very short stature were occasionally treated with injections of growth hormone obtained from the brains of deceased donors. Some of the hormone treatments were unknowingly taken from people who had a natural form of CJD – and several of the recipients went on to get the condition as a result.

 

Alzheimer’s link

 

The connection with Alzheimer’s and other conditions arises because CJD isn’t the only condition in which misfolded proteins play a role. Alzheimer’s has long been suspected of being caused by a build-up of a protein called beta-amyloid. It now seems that, at least in some people, misfolding of amyloid could also be involved.

 

The new study has found suggestions that in eight people who received growth hormone treatments containing misfolded amyloid, all of them either were diagnosed with Alzheimer’s relatively early in life, had signs of it on brain scans or had other forms of cognitive impairment.

 

You can read about this study here. But as it is based on such a small number of people, it shouldn’t be taken as definite proof that Alzheimer’s is transmissible by misfolded proteins, some experts say. But it should raise our suspicions that this is possible.

 

Another piece of evidence supporting this idea is that misfolded amyloid in the walls of blood vessels in the brain can cause stroke. It has recently emerged that, in a few people, this was triggered by misfolded amyloid being seeded into their brains during brain surgery, sometimes decades earlier.

 

If Alzheimer’s and stroke are indeed able to be passed on in this way, it would have some serious consequences. For one thing, some protein-folding disorders can be very infectious if the misfolded proteins are directly introduced into the body. Unlike bacteria or viruses, misfolded proteins may not be destroyed by ordinary procedures for sterilising surgical equipment.

 

If anyone with CJD needs brain surgery, hospitals take extreme steps to avoid contamination, including destroying the surgical instruments used, and they may close the operating theatres to other people that day. Hospitals don’t do that after brain surgery on those with Alzheimer’s disease. As Alzheimer’s is a much more common condition than CJD, the costs and impracticalities of such a policy change make it almost inconceivable.

 

The latest study isn’t yet sufficient evidence for hospitals to change their practice in this way, says Bart De Strooper at University College London. But we should set up rigorous monitoring systems to find out if people are more likely to develop Alzheimer’s if they have had previous neurosurgery, he says.

 

On a brighter note, the new insights about amyloid misfolding may also shed light on Alzheimer’s disease more generally. There is still lots to understand as we don’t know why amyloid builds up in some people and not others, or why some people have high amyloid levels but no dementia symptoms.

 

Anything that can help lead to new treatments for this devastating condition must be welcomed. For a long read on how lifestyle changes can reduce our risk, go here.

 

New Scientist subscriptions

The pursuit of a cleaner world. Image links to offer.

Get access to our expert coverage of the latest breakthroughs in science, including the search for a clean wonder-fuel that could speed our path to net zero. 

Subscribe now
 

The long read: Glucose monitoring

A glucose monitor, in the form of a white disc, on someone's arm

Blood sugar monitoring is becoming more popular

Wirestock/Getty Images

Once I noticed the first one, I saw them everywhere – a curious white disc stuck to the upper arm. People were wearing them at the gym, on the underground, in the office. An internet search told me they were continuous glucose monitors, which give an instant readout of your blood sugar level.

 

Then there was increasing media coverage of ZOE, a dietary advice programme based partly on your blood sugar responses to food, whose podcast recently topped the UK charts. And my social media feeds were filled with posts about how to hack your glucose levels. Clearly, glucose is having a moment.

 

We normally think about blood sugar in relation to diabetes, in which the body can’t regulate glucose levels, with serious health implications. Continuous glucose monitors were invented to make it easier for people with diabetes to find out their blood sugar levels.

 

Now, however, some companies offer them to people without diabetes as part of a programme of personalised nutrition advice. The idea behind monitoring glucose is to reduce the “spikes” that happen after eating, as this will help with weight loss and boost mood, energy levels and sleep, or so the story goes. So, what do we know about the health effects of glucose spikes? And is monitoring them a good idea for everyone or could there be any downsides? I needed to dig into the research and try these monitors for myself.

 

That’s all for this week. If you know someone who might enjoy this newsletter, please forward it to them. 

New Scientist health reporter Clare Wilson

ClareWilson

Health reporter, New Scientist

Email me at healthcheck@newscientist.com
Follow me @clarewilsonmed

Received this from a friend? Sign up here

For the latest science and technology news, in-depth articles and video, visit newscientist.com

 

Facebook TwitterInstagramLinkedIn TikTok

Update preferences  |  Help  |  Contact us

View in browser

This email has been sent to subscriber@example.com. 
 Unsubscribe from the Health Check newsletter

Do not reply directly to this email. If you have an enquiry, please contact us using the relevant contact details listed here.

Copyright © New Scientist Ltd


Registered Office: Northcliffe House, 2 Derry Street, London, W8 5TT
Registered in England. No.10644366
Australian mailing address: PO Box 2315, Strawberry Hills, NSW 2012, Australia
Registered in Australia. ABN 22 621 413 170

 

Privacy Policy  |  Terms & Conditions